$QGEN
Qiagen N.V.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Pl Venlo
QGEN chart
What traders are saying about $QGEN
Latest postsQiagen N.V. news
- PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG
TradingView ·
- QIAGEN N.V. (QIA) Reports BlackRock Voting Rights Notice
TradingView ·
- QIAGEN N.V. (QIA) Discloses BlackRock Voting Rights Notification
TradingView ·
- Release according to Article 40, Section 1 of the WpHG
TradingView ·
- QIAGEN N.V. (QIA): Bank of America Flags 5.83% Stake
TradingView ·
- QIAGEN N.V. (QIA) Notes AFM Voting Rights Disclosure
TradingView ·
- Qiagen N.V. (QGEN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Global DNA Sequencing in Drug Discovery Market Report 2026 | Capitalize on 12.5% CAGR as Illumina, Thermo Fisher, QIAGEN, and Oxford Nanopore Accelerate AI-Driven Precision R&D
Yahoo Finance ·
- Qiagen N.V. (QIA.DE) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Qiagen (NYSE:QGEN) Stock Dropped to "Hold" by DZ Bank
MarketBeat ·
- Can EQT (OM:EQT) Still Be Undervalued Or Is Growth Priced In?
Yahoo Finance ·
- QIAGEN N.V. (QIA) Reports BlackRock Voting Rights Update
TradingView ·
Qiagen N.V. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B |
| Net income | $424.9M | $83.6M | $341.3M | $423.2M |
| Diluted EPS | $1.94 | $0.37 | $1.48 | $1.84 |
| Total assets (year end) | $6.28B | $5.69B | $6.12B | $6.29B |
| Cash and equivalents (year end) | $839.0M | $663.6M | $668.1M | $730.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Qiagen N.V.
- Ticker
- QGEN (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Pl Venlo
- Incorporated in
- Netherlands
- Fiscal year end
- December 31
- SEC CIK
- 1015820
- Former names
- QIAGEN NV
Frequently asked questions
What exchange is Qiagen N.V. listed on?
Qiagen N.V. trades on the NYSE under the ticker symbol QGEN.
What industry is Qiagen N.V. in?
Qiagen N.V. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Qiagen N.V. headquartered?
Qiagen N.V.'s business address on file with the SEC is in Pl Venlo.
When does Qiagen N.V.'s fiscal year end?
Qiagen N.V.'s fiscal year ends on December 31.
How much revenue did Qiagen N.V. report?
Qiagen N.V. reported $2.09B in revenue for calendar year 2025, according to its SEC filings.